2025-03-28
Novo Nordisk is expanding its cash-only savings program offering its blockbuster weight-loss drug Wegovy for $499 a month at all U.S. pharmacies. 23andMe has filed for Chapter 11 bankruptcy protection with CEO Anne Wojcicki stepping down to help with a sale. And the U.S. Department of Health and Human Se [...]
2025-03-24
DNA testing company 23andMe has filed for Chapter 11 bankruptcy, following a tumultuous few years that included significant layoffs and a wide-ranging data breach. It plans to find a buyer and continu [...]
2025-03-07
Novo Nordisk just cut the price of its weight-loss drug, Wegovy, by more than half for patients who pay without insurance. Amgen (AMGN) announced this week that it has begun two late-stage clinical tr [...]
2025-03-25
San Francisco-based 23andMe, which sells at-home DNA testing kits, has filed for bankruptcy in the US and is looking for a new buyer — heightening concerns about the personal data of millions of peo [...]
2025-03-27
The U.S. Department of Health and Human Services (HHS) announced Thursday that it plans to eliminate approximately 3,500 positions at the Food and Drug Administration (FDA), even as the agency’s sta [...]
2025-02-03
Nuance Audio, new "hearing glasses" from EssilorLuxottica, have received FDA clearance and "a CE marking under the Medical Devices regulation in the EU," making them officially rea [...]
2025-03-28
Another week, another trade threat. As financial markets began gearing up for President Donald Trump’s promised reciprocal tariffs, the U.S. announced it would slap 25% tariffs on imported vehicles [...]
2025-03-25
Genetic testing company 23andMe (ME) filed for bankruptcy protection Sunday in the latest stage of a rocky road that included weak consumer demand and a 2023 data breach that jeopardized the genetic d [...]
2025-03-14
An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as it would be easier to manufacture and distribute globally. Three U.S. sen [...]